Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

Author: Tan Jing  

Publisher: Springer Publishing Company

ISSN: 0770-3198

Source: Clinical Rheumatology, Vol.31, Iss.8, 2012-08, pp. : 1169-1175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content